Zurück zu Schlaf
Schlaf

BenzodiazepineStudienlage & Dosis

Sedativum/Hypnotikum — Abhängigkeit, kognitive Risiken im Alter.

Studien zuletzt aktualisiert

Studienlage in Zahlen

Studien gesamt
569
Mit Abstract
50
Meta / Systematic / RCT
4
Häufig zitiert
50
Erscheinungsjahre
1965–2026

Benzodiazepine im Kontext von Schlaf

Dieses Thema ist Teil unserer Welt „Schlaf". Dort findest du Methodik, Studienlage und Hebel mit dem größten Effekt — sowie die Reihenfolge, in der sich Hebel sinnvoll aufeinander aufbauen.

Zur Welt Schlaf

Top-Studien zu Benzodiazepine

Sortiert nach einflussreichen Zitationen und Erscheinungsjahr.

  1. Meta-analysis of benzodiazepine use in the treatment of insomnia.

    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2000n=2.672127 einflussreiche Zitationen

    <h4>Objective</h4>To systematically review the benefits and risks associated with the use of benzodiazepines to treat insomnia in adults.<h4>Data sources</h4>MEDLINE and the Cochrane Controlled Trials Registry were searched for…

  2. Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic attack.

    American journal of respiratory and critical care medicine2000n=116108 einflussreiche Zitationen

    To investigate the prevalence and behavior of sleep-related breathing disorders (SRBDs) associated with a first-ever stroke or transient ischemic attack (TIA), we prospectively studied 161 consecutive patients admitted to our stroke unit.…

  3. A 1,4-benzodiazepine, temazepam (K 3917), its effect on some psychological parameters of sleep and behaviour.

    Arzneimittel-Forschung1975107 einflussreiche Zitationen

    In 30 physically and mentally healthy volunteers, 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-2H-1,4-benzodiazepin-2-one (temazepam, K 3917) was tested for its sleep inducing action, the subjective quality of sleep and any post-medication…

  4. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia.

    Sleep2003n=593105 einflussreiche Zitationen

    <h4>Study objectives</h4>To determine the long-term efficacy of eszopiclone in patients with chronic insomnia.<h4>Design</h4>Randomized, double-blind, multicenter, placebo-controlled.<h4>Setting</h4>Out-patient, with monthly…

  5. Insomnia, self-medication, and relapse to alcoholism.

    The American journal of psychiatry2001n=17295 einflussreiche Zitationen

    <h4>Objective</h4>This study was an investigation of the frequencies of insomnia and its self-medication with alcohol in a group of alcoholic patients, as well as the relationship of these variables to alcoholic relapse.<h4>Method</h4>The…

  6. Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia.

    Drugs200086 einflussreiche Zitationen

    <h4>Unlabelled</h4>Zolpidem is an imidazopyridine agent that is indicated for the short term (< or = 4 weeks) treatment of insomnia (recommended dosage 10 mg/day in adults and 5 or 10 mg/day in the elderly or patients with hepatic…

  7. Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data.

    Addiction (Abingdon, England)200378 einflussreiche Zitationen

    <h4>Aims</h4>The non-benzodiazepine hypnotics zolpidem and zopiclone, which are indicated for short-term treatment of insomnia, were considered originally by physicians as almost devoid of abuse and dependence potential. Several recent…

  8. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease.

    Sleep2003n=15772 einflussreiche Zitationen

    <h4>Objectives</h4>To determine the safety and efficacy of 2 dose formulations of melatonin for the treatment of insomnia in patients with Alzheimer's disease.<h4>Design</h4>A multicenter, randomized, placebo-controlled clinical trial of 2…

  9. Alcohol's effects on sleep in alcoholics.

    Alcohol research &amp; health : the journal of the National Institute on Alcohol Abuse and Alcoholism2001n=74869 einflussreiche Zitationen

    Sleep problems, which can have significant clinical and economic consequences, are more common among alcoholics than among nonalcoholics. During both drinking periods and withdrawal, alcoholics commonly experience problems falling asleep…

  10. Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia.

    The American journal of psychiatry2004n=3868 einflussreiche Zitationen

    <h4>Objective</h4>This study evaluated the effectiveness of a supervised benzodiazepine taper, singly and combined with cognitive behavior therapy, for benzodiazepine discontinuation in older adults with chronic…

Häufige Fragen

Welche Dosierung wurde in den Studien untersucht?
• benzodiazepines
Gibt es Sicherheitshinweise zu Benzodiazepine?
• more patients receiving benzodiazepine treatment reported adverse effects, especially daytime drowsiness and dizziness or light-headedness (common odds ratio 1.8, 95% CI 1.4 to 2.4)

Weitere Themen in Schlaf

Glycin

Glycin, Schlafqualität, Körpertemperatur und Sicherheit.

Alkohol & Schlaf

Schnelleres Einschlafen, aber REM-Suppression und Wach-Phasen.

Antihistaminika

Diphenhydramin, Doxylamin — Schlaf-Frags, anticholinerge Demenz-Risiken.

Apigenin

Kamille, GABA-Modulation und Schlafqualität.

Apigenin (Schlaf)

Flavonoid aus Kamille, GABA-Modulation, Schlafqualität.

Ashwagandha (Schlaf)

Cortisol-Senkung, Schlafqualität — KSM-66 und Sensoril-Extrakte.

Dunkelheit

Blackout-Vorhänge, Schlafmaske — Melatonin und Schlaftiefe.

Raumtemperatur

Optimal 17-19°C — Körperkerntemperatur-Abfall fördert Schlaf.

Blaulichtfilter

f.lux, Night Shift, Brillen — Evidenz und Marketing-Hype.

Bruxismus

Zähneknirschen — Stress, Schiene, Trigger-Faktoren.

Koffein-Timing

Halbwertszeit ~5-6h — Cut-off 8-10h vor Schlaf.

CBD for Sleep

Endocannabinoid-System, REM-Effekte und Dosierungs-Spektrum.

CBT-I

Kognitive Verhaltenstherapie für Insomnie — Erstlinien-Therapie laut Leitlinie.

Circadianer Rhythmus

Innere ~24h-Uhr — Licht als Hauptsignal, periphere Uhren in Organen.

CPAP

Continuous Positive Airway Pressure — Standard bei mittelschwerer Apnoe.

Tiefschlaf

N3-Slow-Wave-Sleep — körperliche Regeneration, GH-Ausschüttung.

GABA Supplements

Blut-Hirn-Schranke, fermentiertes GABA und Wirksamkeits-Daten.

Glycine for Sleep

Tiefschlaf, Körpertemperatur-Senkung und 3g abends.

Glycin (Schlaf)

3g vor dem Schlaf — Körperkerntemperatur-Senkung, Tiefschlaf-Modulation.

Glymphatisches System

Gehirn-Detox während Schlaf — Beta-Amyloid-Clearance.

Verwandte Themen aus anderen Welten